Skip to main content
OpenTrials
Completed

NCT Number: NCT07251946

Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer

This retrospective study included 316 bladder cancer patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bladder Cancer Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Male Urogenital Diseases Neoplasms Neoplasms by Site Urinary Bladder Diseases Urinary Bladder Neoplasms Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Union Hospital，Tongji Medical College，Huazhong University of Science and Technology

Wuhan, Hubei, 430000, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pathological diagnosis of bladder cancer,
  • available clinical information,
  • age >18 years,
  • patients underwent non-contrast and enhanced abdominal CT examination within 4 weeks before cystectomy for bladder cancer.

Exclusion criteria

  • other malignancies in combination,
  • less than one month of follow-up or lack of follow-up,
  • patients with T4b stage,distant metastases (M1 stage)
  • image artefacts or poor quality of image alignment.

Treatment and study plan

Primary outcomes

  1. overall survival

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Lian Yang

Other

Registry information

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Nov 26, 2025
Registry last updated
Nov 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.